Monterey Bio Acquisition closed its IPO of 10 million units. The SPAC also announced that the underwriter had exercised in full its option to purchase 1.5 million additional units, with the option expected to close today.
The aggregate gross proceeds to Monterey Bio from the offering and option exercise is expected to be $115 million.
The SPAC is targeting the biotech industry. Read more.
